Drozitumab
Catalog No.: PC0125
Size: 1 mg, 5 mg
Description
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody that binds the death receptor DR5 and has potent antitumor activity against rhabdomyosarcoma.
| Molecular Weight |
143.1 (kDa) |
| CAS No. |
912628-39-8 |
| Shipping |
Room temperature in continental US; may vary elsewhere. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| In Vitro |
Drozitumab selectively eliminates cancer stem cells (CSCs), resulting in tumor growth inhibition and even regression of pancreatic tumors.
Drozitumab induces apoptosis in mesenchymal TNBC cell lines but not in cell lines from other breast cancer subtypes. |
All of our services are intended for preclinical research
use only and cannot be used to diagnose, treat or manage patients.
